Nemaura Medical to Current on the Planet MIcroCap Showcase:
Loughborough, England, Dec. 01, 2022 (GLOBE NEWSWIRE) — Nemaura Medical, Inc. (Nasdaq: NMRD), a medical expertise firm targeted on creating and commercializing noninvasive wearable diagnostic units and supporting personalised way of life teaching applications, publicizes as we speak that CEO Dr. Faz Chowdhury will current a company overview on the Planet MicroCap Showcase: Digital 2022 being held on December 6 – 8, 2022.
Presentation Date: December 7, 2022
Time: 9:00am EST
Webcast Hyperlink: https://www.webcaster4.com/Webcast/Web page/2937/47190
Dr. Chowdhury shall be accessible for one-on-one investor conferences all through the convention. To attend the convention and request a gathering, register right here:
https://planetmicrocapshowcase.com/signup
About Nemaura Medical, Inc.
Nemaura Medical, Inc. is a medical expertise firm creating and commercializing non-invasive wearable diagnostic units. The corporate is at the moment commercializing sugarBEAT® and proBEAT™. sugarBEAT®, a CE mark authorized Class IIb medical system, is a non-invasive and versatile steady glucose monitor (CGM) offering actionable insights derived from actual time glucose measurements and every day glucose pattern information, which can assist individuals with diabetes and pre-diabetes to higher handle, reverse, and stop the onset of diabetes. Nemaura has submitted a PMA (Premarket Approval Utility) for sugarBEAT® to the U.S. FDA. proBEAT™ combines non-invasive glucose information processed utilizing synthetic intelligence and a digital healthcare subscription service and has been launched within the U.S. as a basic wellness product as a part of its BEAT®diabetes program that’s at the moment present process pilot research.
The Firm sits on the intersection of the worldwide Sort 2 diabetes market that’s anticipated to achieve almost $59 billion by 2025, the $50+ billion pre-diabetic market, and the wearable health-tech sector for weight reduction and wellness functions that’s estimated to achieve $60 billion by 2023.
For extra data, please go to www.NemauraMedical.com.
Contact:
Jules Abraham (Media)
CORE IR
917-885-7378
julesa@coreir.com
Bret Shapiro (Traders)
Senior Managing Accomplice
CORE IR
(561) 479.8566
brets@coreir.com
